Market Research Report
Global Microfluidics Market - 2019-2026
|Published by||DataM Intelligence||Product code||803310|
Delivery time: 1-2 business days
|Global Microfluidics Market - 2019-2026|
|Published: December 1, 2019||Content info:||
Global Microfluidics Market Overview
Microfluidics is the science of manipulating and controlling fluids, usually in the range of microliters (10-6) to picoliters (10-12), in networks of channels with dimensions from tens to hundreds of micrometers. Active microfluidics is a fluid handling device made by active components as microfluidic pumps or microfluidic valves. Microfluidic pumps supply fluids in a continuous way or are used for dosing whereas the microfluidic valves can inject precise volumes of sample or buffer. Microfluidics is often used in lab on a chip and organ on a chip technology. It is also applicable to a wide range of applications, such as; Cosmetics, Pharmaceuticals, personalized medicine & diagnosis, flow synthesis & stoichiometry, cell culture, and 3D printing, and EOR models plasma confinement.
Microfluidics improve the precision of experiments, it provides lower limits of detection, and run multiple analyses simultaneously.
The global microfluidics market was worth $ XX billion in 2018 and is forecasted to reach $ XX billion by 2026, at a CAGR of XX% during the forecast period.
Global Microfluidics Market - Market Dynamics
The rising prevalence of chronic diseases is one of the factor fueling the global Microfluidics market.
The increasing incidence of chronic diseases, with advancements in coagulation tests, blood gas electrolytes, hematology, urine chemistry, and cardiac markers, are creating new opportunities for the growth of the POC diagnostics. which is expected to support the growth of the microfluidics market.
According to National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP), chronic diseases account for more than 75%, 6 IN 10 Adults in the US have a chronic disease, and 4 IN 10 Adults in the US have two or more chronic disease.
Chronic disease is a leading causes of death and disability which have cost USD 3.3 Trillion in Annual Health Care Costs in U.S each year.
According to WHO, in 2017, 30.3 million US adults have diabetes. Diabetes is the seventh leading cause of death in the United States.
Around 630,000 Americans die from heart disease each year. Coronary heart disease is the most common type of heart disease, killing about 366,000 people in 2015.
Global Microfluidics Market - Segment Analysis
Based on component the global market for Microfluidics is broadly segmented as by microfluidic chips, micro pumps, micro needles, and others.
Currently microfluidic chips is the dominant segment and it accounts for approximately XX% of the market, due to the launch of new products and research study on microfluidic chips.
For instance, in May 2018, Imec, the world-leading research and innovation hub in nano-electronics and digital technologies, have introduced a novel organ-on-chip platform for pharmacological studies with unprecedented signal quality. It is developed in collaboration with Micronit Microtechnologies, in which cells can be cultured, providing an environment that mimics human physiology.
In March 2017, Zeon Corporation, have introduced a prototype service using transparent thermoplastic cyclo-olefin polymers for the production of microfluidic chips and other crucial, high-demand medical products.
In April 2016, researchers from Hong Kong Polytechnic University and Zhejiang University in China report integrating fiber optic glucose sensors into a microfluidic chip to create portable, high-performance, low-cost devices for measuring glucose levels.
Global Microfluidics Market - Geographical Analysis
The global microfluidics market is segmented into North America, Europe, Asia Pacific, South America and ROW.
North America is dominating the global microfluidics market, due to the launch of new product and strategic collaboration, which is fueling the market growth.
For instance, in January 2019, L'Oreal have introduced the first wearable microfluidic sensor and companion app to easily measure personal skin pH levels and create customized product regimens to better care for skin. The sensor was co-developed with L'Oreal's skincare brand La Roche-Posay.
In February 2018, researcher from Northwestern University have collaborated with a broad collection of partners including Gatorade, the Seattle Mariners, the U.S. Air Force and the Shirley Ryan AbilityLab to bring his wearable microfluidic sweat analytics system into widespread distribution.The device measures sweat and sweat biomarkers accurately and in real time, allowing athletes, military personnel, fitness pros and others to monitor sweat rate and electrolyte loss.
Global Microfluidics Market - Competitive Analysis
The strategic alliance between companies and research organization for microfluidics is one of the key factor driving the global microfluidics market.
For instance, in December 2017, IDEX Health & Science, LLC have acquired thinXXS Microtechnology, a leader in the development and production of plastic microfluidic consumables serving the Life Sciences, Point of Care, and Veterinary markets. This acquisition will accelerate growth of its microfluidics consumables business.
In November 2018, The University of Toronto have partnered with Canada's National Research Council to create a national innovation hub focused on microfluidics, a field in which tiny amounts of fluid are manipulated in small-scale devices to create everything from portable diagnostic "labs" to repair kits for human organs.